• Educational resources
  • Events
  • Expert Panel
  • Learning Hub
    Learning Hub
    • EoE Learning Hub
    • Chronic Spontaneous Urticaria Learning Hub
    • COPD Learning Hub
    • Rhinology Learning Hub
    • Type 2 Asthma Learning Hub
    • Prurigo Nodularis Learning Hub
    • Atopic Dermatitis Learning Hub
No matches
  • Cookie policy
  • Privacy policy
  • About us
  • Join ADVENT
  • Contact us

ADVENT is a global medical education non-promotional program by Sanofi and Regeneron. This website is intended only for duly authenticated healthcare professionals in Algeria, Argentina, Australia, Austria, Bahrain, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Costa Rica, Croatia, Czech Republic, Denmark, Dominican Republic, Ecuador, Egypt, Estonia, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, Iceland, India, Israel, Italy, Japan, Kuwait, Latvia, Lebanon, Lithuania, Macau, Malaysia, Norway, Oman, Panama, Peru, Poland, Portugal, Qatar, Romania, Saudi Arabia, Singapore, Slovenia, South Africa, South Korea, Spain, Sudan, Sweden, Switzerland, Taiwan, Thailand, The Netherlands, Turkey, United Arab Emirates, or the United States of America.

For healthcare professionals in Algeria: Please read the additional Terms of Use.

Sanofi | Regeneron Logo

© 2026 Sanofi and Regeneron Pharmaceuticals, Inc.

All rights reserved.
MAT-GLB-2302957 - 4.0 - 10/2025

All Rights Reserved.

Sanofi and Regeneron are global leaders in pharmaceutical development, each with a long history of supporting frontline physicians to improve human health and reduce the burden of disease. Driven by the same commitment to patients and their families, Sanofi and Regeneron have partnered to take on type 2 inflammation and the range of chronic conditions in which excessive inflammation plays a role.

Country/region: ChileChange country/region

Educational Resources

Categories
Dermatology: 
  • Atopic dermatitis
  • Chronic pruritus of unknown origin
  • Chronic spontaneous urticaria
  • Prurigo nodularis
Gastroenterology: 
  • Eosinophilic esophagitis
Pulmonology: 
  • Asthma
  • Chronic obstructive pulmonary disease
  • IL-33
Rhinology: 
  • Chronic rhinosinusitis with nasal polyps
Filters
Topic: 
  • Burden of disease
  • Pathophysiology
  • Guidelines and recommendations
  • Clinical management
  • Co-existing type 2 inflammatory diseases
Format: 
  • Expert Video
  • Podcast
  • Slide presentation
  • Infographic
  • Video animation
  • Interactivity
Length: 
  • Short (<5 minutes)
  • Medium (5-15 minutes)
  • Long (> 15 minutes)
Sort by: Newest
  • Newest
  • Oldest
  • A-Z
  • Z-A
The Importance of Early Intervention and the Potential for Disease Modification in Patients With AD
Dermatology
15 min
expert video

The Importance of Early Intervention and the Potential for Disease Modification in Patients With AD

Diving Below the Surface of AD: The Role of Type 2 Inflammation
Dermatology
10 min
expert video

Diving Below the Surface of AD: The Role of Type 2 Inflammation

The Patient Burden of Chronic Pruritus of Unknown Origin (CPUO)
Dermatology
5 min
Infographic

The Patient Burden of Chronic Pruritus of Unknown Origin (CPUO)

Considerations for Disease Modification in AD
Dermatology
3 min
expert video

Considerations for Disease Modification in AD

Emerging Perspectives on the Disease Burden and Management of Children With Atopic Dermatitis
Dermatology
57 min
expert video

Emerging Perspectives on the Disease Burden and Management of Children With Atopic Dermatitis

Type 2 Inflammation and Its Role in Atopic Dermatitis
Dermatology
20 min
expert video

Type 2 Inflammation and Its Role in Atopic Dermatitis

Atopic Dermatitis in Children: Not Just a Skin Disease
Dermatology
20 min
expert video

Atopic Dermatitis in Children: Not Just a Skin Disease

Current and Emerging Therapeutic Options for Children With Atopic Dermatitis
Dermatology
16 min
expert video

Current and Emerging Therapeutic Options for Children With Atopic Dermatitis

Emerging Real-World Data on Advanced Systemic Therapies in AD
Dermatology
5 min
expert video

Emerging Real-World Data on Advanced Systemic Therapies in AD

Early Intervention and the Potential For Disease Modification in AD
Dermatology
5 min
expert video

Early Intervention and the Potential For Disease Modification in AD

The Role of Type 2 Inflammation in Moderate-to-Severe AD
Dermatology
4 min
expert video

The Role of Type 2 Inflammation in Moderate-to-Severe AD

ADVENT On Air - Dermatology
Dermatology
45 min
Podcast

ADVENT On Air | Expert Discussions in Dermatology

    1
    ...
    111213
    ...
    25